Trial Profile
Ibandronic acid versus alendronic acid in postmenopausal Chinese women.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Ibandronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.